Details of issuance or disposal
Issuance of new shares by third-party allotment
2,150,500 common shares
The lower thin line represents the existing number of shares to which these shares will be added.
Total amount payable: ¥199,996,500; estimated net proceeds: ¥194,996,500
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of new shares by third-party allotment |
| Number of shares to be issued or disposed of | 2,150,500 common shares |
| Issue price and disposal price | ¥93 per share |
| Amount of funds to be raised | Total amount payable: ¥199,996,500; estimated net proceeds: ¥194,996,500 |
| Estimated issuance expenses | ¥5,000,000 (calculated as the difference from the total amount payable) |
| Payment date | 10 April 2026 |
| Intended allottee | Senju Pharmaceutical Co., Ltd., 2,150,500 shares |
| Total number of issued shares | 54,831,712 shares → 56,982,212 shares |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The payment procedures for this third-party allotment have been completed. The details of the capital and business alliance and the purpose of the issuance are addressed in a separate notice dated 25 March 2026, and this document does not state specific reasons.